Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo

Breast Cancer Research

Volumn 14, Issue 3, 2012, Pages

  Fleming, Jodie M ^a,b   Miller, Tyler C ^d   Kidacki, Michal ^a   Ginsburg, Erika ^a   Stuelten, Christina H ^b   Stewart, Delisha A ^c   Troester, Melissa A ^c   Vonderhaar, Barbara K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; ESTROGEN; GELATINASE B; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; CELL GROWTH; CELL INTERACTION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENGRAFTMENT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EXPERIMENTAL MODEL; FEMALE; FIBROBLAST; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; IN VIVO STUDY; MACROPHAGE; MAMMARY GLAND; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; CELL MOTION; CYTOLOGY; EXPERIMENTAL NEOPLASM; METABOLISM; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PRENATAL DEVELOPMENT; SIGNAL TRANSDUCTION; UDDER;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINES; CYTOKINES; ESTROGENS; FEMALE; FIBROBLASTS; HUMANS; MACROPHAGES; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED NOD; MICE, SCID; PARACRINE COMMUNICATION; PROLIFERATING CELL NUCLEAR ANTIGEN; SIGNAL TRANSDUCTION; STROMAL CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862604016     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3215     Document Type: Article

References (68)

1. McNally S, Martin F. Molecular regulators of pubertal mammary gland development. Ann Med 2011, 43:212-234. 10.3109/07853890.2011.554425, 21417804.
2. McCave EJ, Cass CA, Burg KJ, Booth BW. The normal microenvironment directs mammary gland development. J Mammary Gland Biol Neoplasia 2010, 15:291-299. 10.1007/s10911-010-9190-0, 20824492.
3. Vonderhaar BK. Regulation of development of the normal mammary gland by hormones and growth factors. Cancer Treat Res 1988, 40:251-266. 10.1007/978-1-4613-1733-3_12, 2908655.
4. Hovey RC, Trott JF, Vonderhaar BK. Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia 2002, 7:17-38. 10.1023/A:1015766322258, 12160083.
5. Ramakrishnan R, Khan SA, Badve S. Morphological changes in breast tissue with menstrual cycle. Mod Pathol 2002, 15:1348-1356. 10.1097/01.MP.0000039566.20817.46, 12481017.
6. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A, Weinberg RA. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 2004, 101:4966-4971. 10.1073/pnas.0401064101, 387357, 15051869.
7. Schwertfeger KL, Rosen JM, Cohen DA. Mammary gland macrophages: pleiotropic functions in mammary development. J Mammary Gland Biol Neoplasia 2006, 11:229-238. 10.1007/s10911-006-9028-y, 17115264.
8. Pollard JW. Role of colony-stimulating factor-1 in reproduction and development. Mol Reprod Dev 1997, 46:54-60. discussion 60-51, 10.1002/(SICI)1098-2795(199701)46:1<54::AID-MRD9>3.0.CO;2-Q, 8981364.
9. Gouon-Evans V, Lin EY, Pollard JW. Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res 2002, 4:155-164. 10.1186/bcr441, 138736, 12100741.
10. Pollard JW, Hennighausen L. Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc Natl Acad Sci USA 1994, 91:9312-9316. 10.1073/pnas.91.20.9312, 44802, 7937762.
11. Gouon-Evans V, Rothenberg ME, Pollard JW. Postnatal mammary gland development requires macrophages and eosinophils. Development 2000, 127:2269-2282.
12. Lanigan F, O'Connor D, Martin F, Gallagher WM. Molecular links between mammary gland development and breast cancer. Cell Mol Life Sci 2007, 64:3159-3184. 10.1007/s00018-007-7386-2, 17955178.
13. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006, 66:605-612. 10.1158/0008-5472.CAN-05-4005, 16423985.
14. Pukrop T, Klemm F, Hagemann T, Gradl D, Schulz M, Siemes S, Trumper L, Binder C. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci USA 2006, 103:5454-5459. 10.1073/pnas.0509703103, 1459376, 16569699.
15. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, Graf T, Pollard JW, Segall J, Condeelis J. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004, 64:7022-7029. 10.1158/0008-5472.CAN-04-1449, 15466195.
16. Ojalvo LS, Whittaker CA, Condeelis JS, Pollard JW. Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol 2010, 184:702-712. 10.4049/jimmunol.0902360, 3226722, 20018620.
17. Mukhtar RA, Nseyo O, Campbell MJ, Esserman LJ. Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn 2011, 11:91-100. 10.1586/erm.10.97, 21171924.
18. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002, 196:254-265. 10.1002/path.1027, 11857487.
19. Proia DA, Kuperwasser C. Reconstruction of human mammary tissues in a mouse model. Nat Protoc 2006, 1:206-214. 10.1038/nprot.2006.31, 17406234.
20. Stewart DA, Yang Y, Makowski L, Troester MA. Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages. Mol Cancer Res 2012, 10:727-738. 10.1158/1541-7786.MCR-11-0604, 22532586.
21. Telenius H, Pelmear AH, Tunnacliffe A, Carter NP, Behmel A, Ferguson-Smith MA, Nordenskjold M, Pfragner R, Ponder BA. Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer 1992, 4:257-263. 10.1002/gcc.2870040311, 1382568.
22. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 1992, 13:718-725. 10.1016/0888-7543(92)90147-K, 1639399.
23. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55:611-622. 10.1373/clinchem.2008.112797, 19246619.
24. Fleming JM, Miller TC, Quinones M, Xiao Z, Xu X, Meyer MJ, Ginsburg E, Veenstra TD, Vonderhaar BK. The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo. BMC Med 2010, 8:27. 10.1186/1741-7015-8-27, 2894739, 20492690.
25. Fotherby K. Endocrinology of menstrual cycle and pregnancy. Biochemistry of Steroid Hormones 1984, 409-440. Oxford: Blackwell Scientific Publications, Making HL.
26. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002, 23:90-119. 10.1210/er.23.1.90, 11844745.
27. Harkonen PL, Vaananen HK. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. Ann NY Acad Sci 2006, 1089:218-227. 10.1196/annals.1386.045, 17261769.
28. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA, Shepard HM. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 1985, 230:943-945. 10.1126/science.3933111, 3933111.
29. Battegay EJ, Raines EW, Colbert T, Ross R. TNF-alpha stimulation of fibroblast proliferation. Dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. J Immunol 1995, 154:6040-6047.
30. Postlethwaite AE, Seyer JM. Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide. J Exp Med 1990, 172:1749-1756. 10.1084/jem.172.6.1749, 2188741, 2258704.
31. Rudolph-Owen LA, Matrisian LM. Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland. J Mammary Gland Biol Neoplasia 1998, 3:177-189. 10.1023/A:1018746923474, 10819526.
32. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000, 36:1621-1630. 10.1016/S0959-8049(00)00156-8, 10959048.
33. Sadlonova A, Novak Z, Johnson MR, Bowe DB, Gault SR, Page GP, Thottassery JV, Welch DR, Frost AR. Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture. Breast Cancer Res 2005, 7:R46-59. 10.1186/bcr949, 1064098, 15642169.
34. Shekhar MP, Werdell J, Santner SJ, Pauley RJ, Tait L. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res 2001, 61:1320-1326.
35. Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y, Bauerlein EL, Hahn WC, Gelman RS, Allred C, Bissell MJ, Schnitt S, Polyak K. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008, 13:394-406. 10.1016/j.ccr.2008.03.007, 18455123.
36. Dong-Le Bourhis X, Berthois Y, Millot G, Degeorges A, Sylvi M, Martin PM, Calvo F. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int J Cancer 1997, 71:42-48. 10.1002/(SICI)1097-0215(19970328)71:1<42::AID-IJC9>3.0.CO;2-3, 9096664.
37. van Roozendaal KE, Klijn JG, van Ooijen B, Claassen C, Eggermont AM, Henzen-Logmans SC, Foekens JA. Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources. Int J Cancer 1996, 65:120-125. 10.1002/(SICI)1097-0215(19960103)65:1<120::AID-IJC20>3.0.CO;2-J, 8543388.
38. Proia DA, Kuperwasser C. Stroma: tumor agonist or antagonist. Cell Cycle 2005, 4:1022-1025. 10.4161/cc.4.8.1903, 16082203.
39. Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 2000, 60:1254-1260.
40. Lin EY, Gouon-Evans V, Nguyen AV, Pollard JW. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 2002, 7:147-162. 10.1023/A:1020399802795, 12465600.
41. Monks J, Henson PM. Differentiation of the mammary epithelial cell during involution: implications for breast cancer. J Mammary Gland Biol Neoplasia 2009, 14:159-170. 10.1007/s10911-009-9121-0, 19408104.
42. Carvalho-Freitas MI, Anselmo-Franci JA, Maiorka PC, Palermo-Neto J, Felicio LF. Prolactin differentially modulates the macrophage activity of lactating rats: possible role of reproductive experience. J Reprod Immunol 2011, 89:38-45. 10.1016/j.jri.2010.12.008, 21420738.
43. O'Brien J, Lyons T, Monks J, Lucia MS, Wilson RS, Hines L, Man YG, Borges V, Schedin P. Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol 2011, 176:1241-1255.
44. Guo JJ, Su FX, Yao HR, Chen JS. Alternatively activated macrophages/mononuclear phagocytes promote growth and invasion of breast cancer cell line SKBR3. Nan Fang Yi Ke Da Xue Xue Bao 2007, 27:410-413.
45. Seta N, Kuwana M. Human circulating monocytes as multipotential progenitors. Keio J Med 2007, 56:41-47. 10.2302/kjm.56.41, 17609587.
46. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661. 10.1126/science.1178331, 2887389, 20133564.
47. Adib-Conquy M, Cavaillon JM. Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression. J Biol Chem 2002, 277:27927-27934. 10.1074/jbc.M200705200, 12032143.
48. Goldman AS, Chheda S, Garofalo R, Schmalstieg FC. Cytokines in human milk: properties and potential effects upon the mammary gland and the neonate. J Mammary Gland Biol Neoplasia 1996, 1:251-258. 10.1007/BF02018078, 10887499.
49. Khalkhali-Ellis Z, Abbott DE, Bailey CM, Goossens W, Margaryan NV, Gluck SL, Reuveni M, Hendrix MJ. IFN-gamma regulation of vacuolar pH, cathepsin D processing and autophagy in mammary epithelial cells. J Cell Biochem 2008, 105:208-218. 10.1002/jcb.21814, 2575810, 18494001.
50. Harvat BL, Jetten AM. Gamma-interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma. Cell Growth Differ 1996, 7:289-300.
51. Grunberg E, Eckert K, Karsten U, Maurer HR. Effects of differentiation inducers on cell phenotypes of cultured nontransformed and immortalized mammary epithelial cells: a comparative immunocytochemical analysis. Tumour Biol 2000, 21:211-223. 10.1159/000030127, 10867614.
52. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW, Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 1990, 87:4828-4832. 10.1073/pnas.87.12.4828, 54211, 2191302.
53. Cohen PE, Chisholm O, Arceci RJ, Stanley ER, Pollard JW. Absence of colony-stimulating factor-1 in osteopetrotic (csfmop/csfmop) mice results in male fertility defects. Biol Reprod 1996, 55:310-317. 10.1095/biolreprod55.2.310, 8828834.
54. Gyorki DE, Asselin-Labat ML, van Rooijen N, Lindeman GJ, Visvader JE. Resident macrophages influence stem cell activity in the mammary gland. Breast Cancer Res 2009, 11:R62. 10.1186/bcr2353, 2750124, 19706193.
55. Vaillant F, Lindeman GJ, Visvader JE. Jekyll or Hyde: does Matrigel provide a more or less physiological environment in mammary repopulating assays?. Breast Cancer Res 2011, 13:108. 10.1186/bcr2851, 3218928, 21635708.
56. Stuelten CH, Barbul A, Busch JI, Sutton E, Katz R, Sato M, Wakefield LM, Roberts AB, Niederhuber JE. Acute wounds accelerate tumorigenesis by a T cell-dependent mechanism. Cancer Res 2008, 68:7278-7282. 10.1158/0008-5472.CAN-08-1842, 2766858, 18794114.
57. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ, Visvader JE. Control of mammary stem cell function by steroid hormone signalling. Nature 2010, 465:798-802. 10.1038/nature09027, 20383121.
58. Eden JA. Breast cancer, stem cells and sex hormones. Part 2: the impact of the reproductive years and pregnancy. Maturitas 2010, 67:215-218. 10.1016/j.maturitas.2010.07.012, 20727695.
59. Fox EM, Andrade J, Shupnik MA. Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways. Steroids 2009, 74:622-627. 10.1016/j.steroids.2008.10.014, 2702758, 18996136.
60. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M, Gustafsson JA. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007, 87:905-931. 10.1152/physrev.00026.2006, 17615392.
61. Troester MA, Lee MH, Carter M, Fan C, Cowan DW, Perez ER, Pirone JR, Perou CM, Jerry DJ, Schneider SS. Activation of host wound responses in breast cancer microenvironment. Clin Cancer Res 2009, 15:7020-7028. 10.1158/1078-0432.CCR-09-1126, 2783932, 19887484.
62. Hinohara K, Gotoh N. Inflammatory signaling pathways in self-renewing breast cancer stem cells. Curr Opin Pharmacol 2010, 10:650-654. 10.1016/j.coph.2010.08.003, 20817605.
63. Goldberg JE, Schwertfeger KL. Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics. Curr Drug Targets 2010, 11:1133-1146. 10.2174/138945010792006799, 20545607.
64. Eichbaum C, Meyer AS, Wang N, Bischofs E, Steinborn A, Bruckner T, Brodt P, Sohn C, Eichbaum MH. Breast cancer cell-derived cytokines, macrophages and cell adhesion: implications for metastasis. Anticancer Res 2011, 31:3219-3227.
65. Hamaguchi T, Wakabayashi H, Matsumine A, Sudo A, Uchida A. TNF inhibitor suppresses bone metastasis in a breast cancer cell line. Biochem Biophys Res Commun 2011, 407:525-530. 10.1016/j.bbrc.2011.03.051, 21414299.
66. Shabo I, Svanvik J. Expression of macrophage antigens by tumor cells. Adv Exp Med Biol 2011, 714:141-150.
67. Lin CW, Shen SC, Ko CH, Lin HY, Chen YC. Reciprocal activation of macrophages and breast carcinoma cells by nitric oxide and colony-stimulating factor-1. Carcinogenesis 2010, 31:2039-2048. 10.1093/carcin/bgq172, 20876703.
68. Berezhnaya NM. Interaction between tumor and immune system: the role of tumor cell biology. Exp Oncol 2010, 32:159-166.